Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Jun 05, 2015 10:28am
89 Views
Post# 23800454

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Potential timeline of BETonMACE news releases?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Potential timeline of BETonMACE news releases?ROTFLMAO...peachfuzz ever the fraud posting pumpertrashole...it is no a "conservative approach" it  is the way trial NR's are typically issued by almost all babybiotechs you scumbag..re. me calling Sarah (whoever she is) why??? only scumbags like you "call" and typically with the specific intent to repurpose the call to enable you to pump something on a MB...she has no authority to speak beyond the official company statements and the company is obligated to NR material news...so are you some sort of crybaby investor who needs to be constantly patted on the head and told everything is OK... not kidding...often what i've discovered is that a "cabal" of fraudsters constantly bombard companies for info then in-private compare notes and then jointly develop trading tactics in the US i believe it is called racketeering...best way for companies to eliminate scum like you is to a) only communicate via  email (and that is the way IMO honest investors communicate) so that there is a 100% verifiable facts" and then b) post all emails (sender name etc blacked out) on their blog..then dirt like you would no longer call and whine like a diapered baby to Sarah (whoever she is)
Bullboard Posts